Lactose (India) Limited (BOM:524202)

India · Delayed Price · Currency is INR

108.10

-0.90 (-0.83%)

At close: Jun 16, 2026

6.92% (1Y)

Market Cap	1.36B +7.6%
Revenue (ttm)	1.63B +40.3%
Net Income	60.63M +17.4%
EPS	4.68 +15.3%
Shares Out	12.59M
PE Ratio	23.10
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,739
Open	109.00
Previous Close	109.00
Day's Range	106.25 - 110.80
52-Week Range	76.01 - 136.70
Beta	0.61
Analysts	n/a
Price Target	n/a
Earnings Date	May 20, 2026

About Lactose (India)

Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally. The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; and liquid dosage forms. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as w... [Read more]

Industry Pharmaceutical Preparations

Founded 1991

Employees 140

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524202

Full Company Profile

Financial Performance

In fiscal year 2026, Lactose (India)'s revenue was 1.63 billion, an increase of 40.28% compared to the previous year's 1.16 billion. Earnings were 60.63 million, an increase of 17.43%.

Financial Statements